Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lifestance Health Group ( (LFST) ) has shared an announcement.
On June 3, 2025, LifeStance Health Group, Inc. held its annual meeting of stockholders, where several key proposals were voted upon. The stockholders elected new directors, ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025, and approved the executive officer compensation on a non-binding advisory basis. These decisions are expected to influence the company’s governance and operational strategies moving forward.
The most recent analyst rating on (LFST) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Lifestance Health Group stock, see the LFST Stock Forecast page.
Spark’s Take on LFST Stock
According to Spark, TipRanks’ AI Analyst, LFST is a Neutral.
LifeStance Health Group’s stock score reflects strong revenue growth and positive developments from the recent earnings call, such as achieving positive net income and operational improvements. However, ongoing profitability challenges, negative free cash flow, and bearish technical indicators weigh on the overall score. The stock’s high valuation further limits its appeal.
To see Spark’s full report on LFST stock, click here.
More about Lifestance Health Group
LifeStance Health Group, Inc. operates in the healthcare industry, focusing on mental health services. The company offers a range of mental health care solutions, aiming to improve the lives of individuals through accessible and affordable care.
Average Trading Volume: 1,898,199
Technical Sentiment Signal: Sell
Current Market Cap: $2.31B
For detailed information about LFST stock, go to TipRanks’ Stock Analysis page.